Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia

N/ACompletedNCT01988532

Novo Nordisk A/S381 enrolled

Overview

This study is conducted in the United States of America (USA). The aim of the study is to assess the impact of pain on functional impairment and quality of life in adult persons with hemophilia (PWH) with and without inhibitors with joint bleeding.

Study Type

OBSERVATIONAL

Enrollment

381

Conditions

Congenital Bleeding Disorder Haemophilia A Haemophilia A With Inhibitors Haemophilia B Haemophilia B With Inhibitors

Interventions

No treatment givenOTHER

Subject will only fill out a questionnaire

Eligibility

Sex: MALE

Medical Language ↔ Plain English

Inclusion Criteria: * Adult males able to provide consent and complete a survey in English * Congenital hemophilia A or B with or without inhibitors with any history of joint bleeding or joint pain * Presentation at the treatment center for a comprehensive annual visit where joint range of motion will be obtained * Informed consent obtained before any study-related activities. (Study-related activities are any procedure related to recording of data according to the protocol) Exclusion Criteria: * Previous participation in this study

Locations (1)

Novo Nordisk Investigational Site

Plainsboro, New Jersey, United States

Outcomes

Primary Outcomes

Prevalence of acute (bleed-related) pain (percentage)

Time frame: At the first visit (only one study visit)

Prevalence of chronic (arthritic) pain (percentage)

Time frame: At the first visit (only one study visit)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.